ORIS
The computed 12-month bankruptcy probability of ORIS is 0.3% (very low). The 2024 annual accounts show equity of €119k and a net result of €-56k. Its solvency ranks better than 25% of 381 sector peers (fiscal year 2024). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €119k |
| Net result | €-56k |
| Better than sector | 25% |
| Active | 2 yrs |
Fragile profile, watch profitability in particular.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 14.2% | 50.2% | |
| Net result | €-56k | €72k | |
| Equity | €119k | €128k | |
| Gross operating margin | €-39k | €180k | |
| Total assets | €843k | €553k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-40k |
| Net profit | €-56k |
| Cash flow | €-48k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €843k |
| Equity | €119k |
| Debt | €723k |
| of which ≤ 1y | €126k |
| of which > 1y | €595k |
| Working capital | €-44k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.65 |
| Quick ratio | 0.65 |
| Working capital ratio | -5.2% |
| Solvency | 14.2% |
| Debt / equity | 6.05 |
| Long-term debt ratio | 4.98 |
| Interest coverage | -5.36 |
| Gross margin | - |
| Net margin | - |
| ROA | -6.6% |
| ROE | -46.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €843k |
| Fixed assets | 21/28 | €761k |
| Tangible fixed assets | 22/27 | €761k |
| Current assets | 29/58 | €82k |
| Amounts receivable within one year | 40/41 | €7k |
| Cash & bank | 54/58 | €74k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €843k |
| Equity | 10/15 | €119k |
| Contributions / capital | 10/11 | €175k |
| Accumulated profits (losses) | 14 | €-56k |
| Amounts payable | 17/49 | €723k |
| Amounts payable after one year | 17 | €595k |
| Amounts payable within one year | 42/48 | €126k |
| Trade debts payable within one year | 44 | €42k |
| Income statement | ||
| Gross operating margin | 9900 | €-39k |
| Operating result | 9901 | €-48k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €8k |
| Result before taxes | 9903 | €-56k |
| Net result for the period | 9904 | €-56k |
| Result to be appropriated | 9905 | €-56k |
| NACE primary | Human health(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 21-03-2024 |
| Status | Active |
| Postal code | 3300 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24592F0440/00Y000 | Flanders | 1,416 m² | 1 · 857 m² | 24.8 m · 1 fl. |
| 24107B0314/00H002 | Flanders | 570 m² | 1 · 127 m² | 11.3 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
10-03-2025 Discharge granted to the board
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "LEU",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-03-10",
"filing_date": "2025-02-27",
"act_kind_objet": "Benoeming"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2025-02-10",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "1007.427.053",
"name_full": "ORIS",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Arno Maes",
"org_rep_person_name": null,
"person_role_at_subject": "vaste vertegenwoordiger"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | ORIS |